• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响多发性硬化症患者疲劳感的临床变量:使用 FSIQ-RMS 的横断面研究。

Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS.

机构信息

MS Center, S. Andrea Hospital, Sapienza University, Rome, Italy.

Department of Human Neurosciences, Sapienza University, Rome, Italy.

出版信息

BMC Neurol. 2024 Apr 25;24(1):138. doi: 10.1186/s12883-024-03643-x.

DOI:10.1186/s12883-024-03643-x
PMID:38664640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11044535/
Abstract

BACKGROUND

Physical fatigue is one of the most disabling symptoms in people with Multiple Sclerosis (PwMS). Several factors might influence the development of fatigue, such as gender, education, body mass index (BMI), Expanded Disability Status Scale (EDSS), disease duration, working status (Ws), physiotherapy (Ph), and disease-modifying therapies (DMTs). Fatigue Symptoms and Impacts Questionnaire-Relapsing Multiple Sclerosis (FSIQ-RMS) is a patient-reported outcome (PRO) that allows one to define the impact of fatigue in PwMS clearly. This study aimed to assess fatigue impact on PwMS by using FSIQ-RMS.

METHODS

The participants were enrolled from May to July 2021 in MS Centers of Sant'Andrea Hospital and Policlinico Umberto I Hospital in Rome. Fatigue was evaluated using the FSIQ-RMS, validated, and culturally adapted in Italian. Clinical and demographic data were collected at the same time.

RESULTS

We enrolled 178 PwMS [Female 74.16%; RMS 82.58%, SPMS 17.52%]. FSIQ-RMS scores were significantly correlated with EDSS (p-value < 0.01). Analysis of variance between means showed a statistically significant difference between the BMI groups at the 24hours_FSIQ-RMS score and the 7days_FSIQ-RMS score (p < 0.01), with the lower BMI group having the highest scores. Furthermore, perceived fatigue significantly improved both in subjects performing Ph (p < 0.05) and in those who actively work (p < 0.01).

CONCLUSIONS

The use of FSIQ-RMS in a real-world setting confirmed that underweight and high levels of disability are closely related to fatigue. In addition, Ph and active Ws are strongly correlated with fatigue in PwMS.

摘要

背景

身体疲劳是多发性硬化症(MS)患者最致残的症状之一。多种因素可能会影响疲劳的发展,如性别、教育程度、体重指数(BMI)、扩展残疾状态量表(EDSS)、病程、工作状态(Ws)、物理治疗(Ph)和疾病修正治疗(DMTs)。疲劳症状和影响问卷-复发型多发性硬化症(FSIQ-RMS)是一种患者报告的结局(PRO),可以明确定义 MS 患者疲劳的影响。本研究旨在使用 FSIQ-RMS 评估疲劳对 MS 患者的影响。

方法

研究对象于 2021 年 5 月至 7 月在罗马圣安德烈亚医院和翁贝托一世医院的 MS 中心入组。使用经过验证和文化适应性改编的意大利语版本的 FSIQ-RMS 评估疲劳。同时收集临床和人口统计学数据。

结果

共纳入 178 例 MS 患者[女性占 74.16%;复发型 MS(RMS)占 82.58%,继发进展型 MS(SPMS)占 17.52%]。FSIQ-RMS 评分与 EDSS 显著相关(p 值<0.01)。平均值之间的方差分析显示,24 小时 FSIQ-RMS 评分和 7 天 FSIQ-RMS 评分的 BMI 组之间存在统计学差异(p<0.01),较低的 BMI 组得分最高。此外,进行 Ph 的患者(p<0.05)和积极工作的患者(p<0.01)的主观疲劳感均显著改善。

结论

FSIQ-RMS 在真实环境中的使用证实,体重不足和高残疾水平与疲劳密切相关。此外,Ph 和积极的 Ws 与 MS 患者的疲劳密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85a4/11044535/09fbd5bca7a1/12883_2024_3643_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85a4/11044535/c189f39af0ea/12883_2024_3643_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85a4/11044535/2df8b57daac2/12883_2024_3643_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85a4/11044535/3f145776ecd7/12883_2024_3643_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85a4/11044535/09fbd5bca7a1/12883_2024_3643_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85a4/11044535/c189f39af0ea/12883_2024_3643_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85a4/11044535/2df8b57daac2/12883_2024_3643_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85a4/11044535/3f145776ecd7/12883_2024_3643_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85a4/11044535/09fbd5bca7a1/12883_2024_3643_Fig4_HTML.jpg

相似文献

1
Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS.影响多发性硬化症患者疲劳感的临床变量:使用 FSIQ-RMS 的横断面研究。
BMC Neurol. 2024 Apr 25;24(1):138. doi: 10.1186/s12883-024-03643-x.
2
Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS).疲劳症状和影响问卷在复发型多发性硬化症中的意大利语翻译和验证 (FSIQ-RMS)。
Neurol Sci. 2022 Aug;43(8):4925-4932. doi: 10.1007/s10072-022-06080-1. Epub 2022 Apr 22.
3
A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world study.一种新的疾病特异性量表,用于描述美国复发型多发性硬化症成年患者疲劳的症状和影响:一项真实世界研究。
Mult Scler Relat Disord. 2022 Mar;59:103637. doi: 10.1016/j.msard.2022.103637. Epub 2022 Jan 29.
4
Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.FSIQ-RMS 的制定与验证:一种新的患者报告问卷,用于评估复发型多发性硬化症的疲劳症状和影响。
Value Health. 2019 Apr;22(4):453-466. doi: 10.1016/j.jval.2018.11.007. Epub 2019 Feb 21.
5
Meaningful Change Thresholds and Fatigue Severity Points on Patient-Reported Outcomes by the Fatigue Symptoms and Impacts Questionnaire in Patients With Relapsing Multiple Sclerosis.多发性硬化症患者疲劳症状和影响问卷的患者报告结局的有意义变化阈值和疲劳严重程度点。
Value Health. 2024 May;27(5):598-606. doi: 10.1016/j.jval.2024.02.006. Epub 2024 Feb 23.
6
Prevalence of Walking-Related Motor Fatigue in Persons With Multiple Sclerosis: Decline in Walking Distance Induced by the 6-Minute Walk Test.多发性硬化症患者步行相关运动疲劳的患病率:6分钟步行试验导致的步行距离下降
Neurorehabil Neural Repair. 2016 May;30(4):373-83. doi: 10.1177/1545968315597070. Epub 2015 Jul 27.
7
Factors that influence quality of life in patients with multiple sclerosis in Saudi Arabia.影响沙特阿拉伯多发性硬化症患者生活质量的因素。
Disabil Rehabil. 2022 Aug;44(17):4775-4783. doi: 10.1080/09638288.2021.1919929. Epub 2021 May 9.
8
Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and clinicians.多发性硬化症患者的认知障碍:感知与表现——促使患者和临床医生对障碍产生不同感知的因素。
Mult Scler Relat Disord. 2023 Jan;69:104410. doi: 10.1016/j.msard.2022.104410. Epub 2022 Nov 13.
9
Comparison of patient-reported outcomes of physical activity and accelerometry in people with multiple sclerosis and ambulatory impairment: A cross-sectional study.多发性硬化症伴活动障碍患者身体活动和加速度计患者报告结局的比较:一项横断面研究。
Mult Scler Relat Disord. 2024 May;85:105532. doi: 10.1016/j.msard.2024.105532. Epub 2024 Mar 1.
10
Occupational performance in multiple sclerosis and its relationship with quality of life and fatigue.多发性硬化症患者的职业表现及其与生活质量和疲劳的关系。
Eur J Phys Rehabil Med. 2020 Apr;56(2):148-154. doi: 10.23736/S1973-9087.20.05914-6. Epub 2020 Jan 23.

引用本文的文献

1
Effect of a nurse-led online patient support program on fatigue, sleep and quality of life in patients with multiple sclerosis: a quasi-experimental study.护士主导的在线患者支持项目对多发性硬化症患者疲劳、睡眠及生活质量的影响:一项准实验研究
BMC Neurol. 2025 May 31;25(1):238. doi: 10.1186/s12883-025-04248-8.
2
Validation of the Italian Version of the Scale for the Assessment and Rating of Ataxia (SARA) in Multiple Sclerosis: A Cross-Sectional Study.意大利版共济失调评估与评分量表(SARA)在多发性硬化症中的效度验证:一项横断面研究。
Cerebellum. 2025 Mar 19;24(3):66. doi: 10.1007/s12311-025-01813-2.
3
The Innovative XClinic Tool: A Pilot Study Validating Its Precision in Measuring Range of Motion in Healthy Individuals.

本文引用的文献

1
Association between improved metabolic risk factors and perceived fatigue during dietary intervention trial in relapsing-remitting multiple sclerosis: A secondary analysis of the WAVES trial.复发缓解型多发性硬化症饮食干预试验中代谢危险因素改善与感知疲劳之间的关联:WAVES试验的二次分析
Front Neurol. 2023 Jan 19;13:1022728. doi: 10.3389/fneur.2022.1022728. eCollection 2022.
2
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort.全国多发性硬化症队列中患者报告的疲劳症状严重程度的预测因素
Mult Scler Relat Disord. 2023 Feb;70:104481. doi: 10.1016/j.msard.2022.104481. Epub 2022 Dec 23.
3
创新的XClinic工具:一项验证其在测量健康个体运动范围方面精度的试点研究。
Sensors (Basel). 2025 Feb 21;25(5):1331. doi: 10.3390/s25051331.
4
Efficacy of Prehabilitation in cancer patients: an Rcts systematic review with meta-analysis.术前康复治疗对癌症患者的疗效:一项 RCTs 的系统评价和荟萃分析。
BMC Cancer. 2024 Oct 22;24(1):1302. doi: 10.1186/s12885-024-13023-w.
Determinants of early working impairments in multiple sclerosis.
多发性硬化症早期工作障碍的决定因素。
Front Neurol. 2022 Dec 9;13:1062847. doi: 10.3389/fneur.2022.1062847. eCollection 2022.
4
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis.进展性多发性硬化症中疲劳与双任务表现的结构和功能磁共振成像相关性
J Neurol. 2023 Mar;270(3):1543-1563. doi: 10.1007/s00415-022-11486-0. Epub 2022 Nov 27.
5
Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS).疲劳症状和影响问卷在复发型多发性硬化症中的意大利语翻译和验证 (FSIQ-RMS)。
Neurol Sci. 2022 Aug;43(8):4925-4932. doi: 10.1007/s10072-022-06080-1. Epub 2022 Apr 22.
6
Intensive Circuit Class Therapy in Patients with Relapsing-Remitting Multiple Sclerosis.强化回路式训练疗法治疗复发缓解型多发性硬化症患者
J Rehabil Med. 2022 Mar 29;54:jrm00267. doi: 10.2340/jrm.v54.2027.
7
Fitness, physical activity, and exercise in multiple sclerosis: a systematic review on current evidence for interactions with disease activity and progression.多发性硬化症中的健康、体力活动和运动:对当前与疾病活动和进展相互作用的证据的系统评价。
J Neurol. 2022 Jun;269(6):2922-2940. doi: 10.1007/s00415-021-10935-6. Epub 2022 Jan 27.
8
Efficacy of high-intensity aerobic exercise on common multiple sclerosis symptoms.高强度有氧运动对常见多发性硬化症症状的疗效。
Acta Neurol Scand. 2022 Feb;145(2):229-238. doi: 10.1111/ane.13540. Epub 2021 Oct 22.
9
Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.在主动对照 3 期 OPTIMUM 研究中,与特立氟胺相比,ponesimod 治疗活跃期多发性硬化症的患者:一项随机临床试验。
JAMA Neurol. 2021 May 1;78(5):558-567. doi: 10.1001/jamaneurol.2021.0405.
10
Efficacy classification of modern therapies in multiple sclerosis.多发性硬化症现代疗法的疗效分类。
J Comp Eff Res. 2021 Apr;10(6):495-507. doi: 10.2217/cer-2020-0267. Epub 2021 Feb 23.